Methods to manufacture 1,3-dioxolane nucleosides
    5.
    发明授权
    Methods to manufacture 1,3-dioxolane nucleosides 有权
    1,3-二氧戊环核苷的制备方法

    公开(公告)号:US08420354B2

    公开(公告)日:2013-04-16

    申请号:US12870319

    申请日:2010-08-27

    摘要: This application provides a process for preparing enantiomerically pure β-D-dioxolane nucleosides. In particular, a new synthesis of (−)-DAPD, suitable for large scale development, is described. In one embodiment the invention provides a process for preparing a substantially pure β-D- or β-L-1,3-dioxolane nucleosides comprising a) preparing or obtaining an esterified 2,2-dialkoxy ethanol; b) cyclizing the esterified 2,2-dialkoxy ethanol with glycolic acid to obtain a 1,3-dioxolane lactone; c) resolving the 1,3-dioxolane lactone to obtain a substantially pure D- or L-lactone; d) selectively reducing and activating the D- or L-chiral lactone to obtain a substantially pure D- or L-1,3-dioxolane; e) coupling the D- or L-1,3-dioxolane to an activated and/or protected purine or pyrimidine base; and f) optionally purifying the nucleoside to obtain a substantially pure protected β-D- or β-L-1,3-dioxolane nucleoside.

    摘要翻译: 本申请提供了制备对映异构体纯的对二氧戊环核苷的方法。 特别地,描述了适用于大规模开发的( - ) - DAPD的新合成。 在一个实施方案中,本发明提供了制备基本上纯的二 - 或 - bgr--L-1,3-二氧戊环核苷的方法,其包括a)制备或获得酯化的2,2-二烷氧基乙醇; b)用乙醇酸环化酯化的2,2-二烷氧基乙醇得到1,3-二氧戊环内酯; c)拆分1,3-二氧戊环内酯以获得基本上纯的D-或L-内酯; d)选择性还原和活化D-或L-手性内酯,得到基本上纯的D-或L-1,3-二氧戊环; e)将D-或L-1,3-二氧戊环与活化和/或受保护的嘌呤或嘧啶碱基偶联; 和f)任选地纯化所述核苷以获得基本上纯的保护的-β-或 - bgr; -L-1,3-二氧戊环核苷。

    Methods to Manufacture 1,3-Dioxolane Nucleosides
    6.
    发明申请
    Methods to Manufacture 1,3-Dioxolane Nucleosides 有权
    1,3-二氧戊环核苷的制备方法

    公开(公告)号:US20110130559A1

    公开(公告)日:2011-06-02

    申请号:US12870319

    申请日:2010-08-27

    IPC分类号: C07H19/16

    摘要: This application provides a process for preparing enantiomerically pure β-D-dioxolane nucleosides. In particular, a new synthesis of (−)-DAPD, suitable for large scale development, is described. In one embodiment the invention provides a process for preparing a substantially pure β-D- or β-L-1,3-dioxolane nucleosides comprising a) preparing or obtaining an esterified 2,2-dialkoxy ethanol; b) cyclizing the esterified 2,2-dialkoxy ethanol with glycolic acid to obtain a 1,3-dioxolane lactone; c) resolving the 1,3-dioxolane lactone to obtain a substantially pure D- or L-lactone; d) selectively reducing and activating the D- or L-chiral lactone to obtain a substantially pure D- or L-1,3-dioxolane; e) coupling the D- or L-1,3-dioxolane to an activated and/or protected purine or pyrimidine base; and f) optionally purifying the nucleoside to obtain a substantially pure protected β-D- or β-L-1,3-dioxolane nucleoside.

    摘要翻译: 本申请提供了制备对映异构体纯的对二氧戊环核苷的方法。 特别地,描述了适用于大规模开发的( - ) - DAPD的新合成。 在一个实施方案中,本发明提供了制备基本上纯的二 - 或 - bgr--L-1,3-二氧戊环核苷的方法,其包括a)制备或获得酯化的2,2-二烷氧基乙醇; b)用乙醇酸环化酯化的2,2-二烷氧基乙醇得到1,3-二氧戊环内酯; c)拆分1,3-二氧戊环内酯以获得基本上纯的D-或L-内酯; d)选择性还原和活化D-或L-手性内酯,得到基本上纯的D-或L-1,3-二氧戊环; e)将D-或L-1,3-二氧戊环与活化和/或受保护的嘌呤或嘧啶碱基偶联; 和f)任选地纯化所述核苷以获得基本上纯的保护的β-和/或b-l-1,3-二氧戊环核苷。